The National Alzheimer’s Coordinating Center (NACC) has a large collection of brain autopsy data with state-of-the-art quantifications of AD neuropathology, providing a unique opportunity to examine the heterogeneous impact of APOE4 on mortality risk. This evidence concerns the gene APOE and Alzheimer disease.